Tag Archives: bortezomib; carfilzomib; multiple myeloma; proteasome inhibitor; relapsed; refractory

Replacement of Bortezomib with Carfilzomib for Multiple Myeloma Patients Progressing from Bortezomib Combination Therapy

March 5, 2017


J R Berenson1,2,3, J D Hilger2, O Yellin2, R Dichmann4, D Patel-Donnelly5, R V Boccia6, A Bessudo7, L Stampleman8, D Gravenor9, S Eshaghian10, Y Nassir11, R A Swift3 and R A Vescio10 1Department of Hematology/Oncology, Institute for Myeloma and Bone Cancer Research, West Hollywood, CA, USA 2Oncotherapeutics, West Hollywood, CA, USA 3James R Berenson, MD, Inc., West Hollywood, CA, USA 4Department of Medical Oncology and Hematology, Central Coast […]

Continue reading...
Scroll Up